Asston Pharmaceuticals Limited has intimated BSE Limited about an upcoming Board of Directors meeting scheduled for Tuesday, 13th October, 2026. The intimation is made pursuant to Regulation 29(1) of the SEBI Listing Regulations.
The Board will consider and approve the following agenda items:
- Shifting of the registered office address of the Company
- Acquisition of immovable property through Bank/Financial Institution Auction
- Other incidental matters
The communication was signed by Rishi Upadhaya, Company Secretary & Compliance Officer (Membership Number: A74324), on behalf of the Board of Directors. The document was digitally signed on 06th October, 2026 at 18:14:43 IST.
The company's current registered office is at 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India. Company Identification Number is U24304MH2019PLC324187.
Financial impact of the proposed actions (office shifting and property acquisition) is not quantified in the disclosure.